TY - JOUR
T1 - Stability of serum high-density lipoprotein-microRNAs for preanalytical conditions
AU - Ishikawa, Hiroaki
AU - Yamada, Hiroya
AU - Taromaru, Nao
AU - Kondo, Kanako
AU - Nagura, Ayuri
AU - Yamazaki, Mirai
AU - Ando, Yoshitaka
AU - Munetsuna, Eiji
AU - Suzuki, Koji
AU - Ohashi, Koji
AU - Teradaira, Ryoji
N1 - Publisher Copyright:
© 2016, © The Author(s) 2016.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Background: Recently, several studies have shown that microRNAs are present in high-density lipoprotein, and high-density lipoprotein-microRNA may be a promising disease biomarker. We investigated the stability of high-density lipoprotein-microRNAs in different storage conditions as this is an important issue for its application to the field of clinical research. Methods: microRNAs were extracted from the high-density lipoprotein fraction that was purified from the serum. miR-135 a and miR-223, which are known to be present in high-density lipoprotein, were quantified by quantitative real-time PCR. The influence of preanalytical parameters on the analysis of high-density lipoprotein-miRNAs was examined by the effect of RNase, storage conditions, and freezing and thawing. Results: The concentrations of microRNA in high-density lipoprotein were not altered by RNase A treatment (0–100 U/mL). No significant change in these microRNAs was observed after storing serum at room temperature or 4℃ for 0–24 h, and there was a similar result in the cryopreservation for up to two weeks. Also, high-density lipoprotein-microRNAs were stable for, at least, up to five freeze–thaw cycles. Conclusions: These results demonstrated that high-density lipoprotein-microRNAs are relatively resistant to various storage conditions. This study provides new and important information on the stability of high-density lipoprotein-microRNAs.
AB - Background: Recently, several studies have shown that microRNAs are present in high-density lipoprotein, and high-density lipoprotein-microRNA may be a promising disease biomarker. We investigated the stability of high-density lipoprotein-microRNAs in different storage conditions as this is an important issue for its application to the field of clinical research. Methods: microRNAs were extracted from the high-density lipoprotein fraction that was purified from the serum. miR-135 a and miR-223, which are known to be present in high-density lipoprotein, were quantified by quantitative real-time PCR. The influence of preanalytical parameters on the analysis of high-density lipoprotein-miRNAs was examined by the effect of RNase, storage conditions, and freezing and thawing. Results: The concentrations of microRNA in high-density lipoprotein were not altered by RNase A treatment (0–100 U/mL). No significant change in these microRNAs was observed after storing serum at room temperature or 4℃ for 0–24 h, and there was a similar result in the cryopreservation for up to two weeks. Also, high-density lipoprotein-microRNAs were stable for, at least, up to five freeze–thaw cycles. Conclusions: These results demonstrated that high-density lipoprotein-microRNAs are relatively resistant to various storage conditions. This study provides new and important information on the stability of high-density lipoprotein-microRNAs.
UR - http://www.scopus.com/inward/record.url?scp=85006817472&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85006817472&partnerID=8YFLogxK
U2 - 10.1177/0004563216647086
DO - 10.1177/0004563216647086
M3 - Article
C2 - 27166305
AN - SCOPUS:85006817472
SN - 0004-5632
VL - 54
SP - 134
EP - 142
JO - Annals of Clinical Biochemistry
JF - Annals of Clinical Biochemistry
IS - 1
ER -